The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Official Title: An Open-label Phase 3 Trial to Evaluate the Safety and Tolerability of Egalet ADER Oxycodone Tablet, Egalet-002, in Patients With Moderate-to-Severe Chronic Noncancer Pain
Study ID: NCT02603705
Brief Summary: The purpose of this study is to evaluate the safety and tolerability of Egalet-002 in opioid-experienced patients with moderate-to-severe chronic noncancer pain.
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Site 334, Huntsville, Alabama, United States
Site 328, Tucson, Arizona, United States
Site 332, Jacksonville, Florida, United States
Site 340, Miami Gardens, Florida, United States
Site 320, Plantation, Florida, United States
Site 302, Tampa, Florida, United States
Site 315, Tampa, Florida, United States
Site 310, Winter Haven, Florida, United States
Site 316, Dawsonville, Georgia, United States
Site 311, Marietta, Georgia, United States
Site 336, Bloomington, Illinois, United States
Site 345, Blue Island, Illinois, United States
Site 304, Evansville, Indiana, United States
Site 325, Valparaiso, Indiana, United States
Site 321, Overland Park, Kansas, United States
Site 342, Wichita, Kansas, United States
Site 329, New Orleans, Louisiana, United States
Site 326, Quincy, Massachusetts, United States
Site 303, Saint Louis, Missouri, United States
Site 306, Las Vegas, Nevada, United States
Site 313, Belvidere, New Jersey, United States
Site 346, Blackwood, New Jersey, United States
Site 323, Hartsdale, New York, United States
Site 338, Mooresville, North Carolina, United States
Site 333, Cincinnati, Ohio, United States
Site 343, Cleveland, Ohio, United States
Site 308, Huber Heights, Ohio, United States
Site 347, Kettering, Ohio, United States
Site 335, Oklahoma City, Oklahoma, United States
Site 312, Eugene, Oregon, United States
Site 322, Duncansville, Pennsylvania, United States
Site 324, Wyomissing, Pennsylvania, United States
Site 344, Myrtle Beach, South Carolina, United States
Site 314, Summerville, South Carolina, United States
Site 341, New Tazewell, Tennessee, United States
Site 318, Austin, Texas, United States
Site 330, Dallas, Texas, United States
Site 309, San Antonio, Texas, United States
Site 331, West Jordan, Utah, United States